Search results for Glp-1 Ras (Drug)

GLP-1 drugs reduce risk of major adverse cardiovascular events

New research has shown that GLP‑1 weight-loss drugs deliver protection against heart attacks, strokes and premature death over a sustained period of time.

GLP-1s may not raise DKA, pancreatitis risk in type 1 diabetes

LAS VEGAS — GLP-1 receptor agonists may not raise the risk for diabetic ketoacidosis or pancreatitis among adults with type 1 diabetes, according to the findings from a single-cent...

GLP-1s reduced ED visits, infections and revisions in orthopedics

NEW ORLEANS — Results presented here showed GLP-1 receptor agonists may be associated with lower ED utilization and a reduction in surgical site infections and revisions for a rang...

GLP-1 Meds May Help Slow the Spread of Certain Obesity-Related Cancers

WEDNESDAY, May 27, 2026 — A new study suggests GLP-1 medications may slow the spread of certain obesity-related cancers. "GLP-1 receptor agonists have never been just glucose-lower...

Popular GLP-1 weight-loss drugs like Ozempic slash heart attack and stroke risk

A huge international review found that GLP-1 weight-loss drugs significantly reduce the risk of heart attacks, strokes, heart failure, and premature death over the long term. Resea...

Best GLP-1 Drug on the Market Is Even Better Than We Knew

Study finds nutritional risks in users of GLP-1 drugs

Adults with overweight or obesity taking the new generation of weight loss drugs semaglutide and tirzepatide tend to eat significantly less, leaving them vulnerable to nutritional...

How safe are GLP-1 drugs, really?

GLP-1 medications have exploded in popularity over the past few years, and it’s easy to see why. They work. People lose significant weight, blood sugar improves, and for the first...

GLP-1 Drugs May Improve Breast Cancer Outcomes

WEDNESDAY, May 13, 2026 — Popular GLP-1 medications may be linked to better long-term outcomes for some breast cancer patients. Previous research has shown breast cancer survivors...

GLP-1s Now Linked To Lower Risk Of 4 Different Cancerous Tumors

What started as a diabetes medication has rapidly become one of the most talked-about drug categories in modern medicine. GLP-1 medications such as Ozempic, Wegovy,...

GLP-1 Drugs May Cut Risk of Heart Attack, Stroke, and Death by About 13 Percent

Learn how GLP-1 drugs may protect the heart by lowering inflammation, improving blood vessels, and reducing key risk factors.

GLP-1 Receptor Agonists and Upper Endoscopy – Guidance for Periprocedural Management

GLP-1 and dual GLP-1 / GIP drugs help lose body fat while preserving lean mass

New research to be presented at this year's European Congress on Obesity (ECO 2025, Malaga, Spain, 11-14 May) shows that patients using GLP-1 or combined GLP-1 / GIP receptor agoni...

GLP-1 Drugs Offer Real Hope for People With Pain or Addiction

By Dr. Lynn WebsterIn Greek mythology, the goddess Panacea carried a potion that could heal any disease. It’s a seductive image, and it’s how GLP-1 drugs can start to feel as repor...

GLP-1 drugs may reduce the risk of cancer progressing, study suggests

GLP-1 drugs may be linked to a lower risk of cancer progression, according to new research that will be presented next week at the American Society of Clinical Oncology’s annual me...

ACI’s 2nd Annual Summit on GLP-1 Law & Policy

ACI’s 2nd Annual Summit on GLP-1 Law & Policy Anonymous (not verified) Mon, 04/20/2026 - 08:10 pharmagather item url ACI’s 2nd Annual Summit on GLP-1 L...

D&D sees fibrosis improvements, MASH resolution after rolling dice on GLP-1 drug

D&D Pharmatech has linked its GLP-1/glucagon receptor agonist to improvements in liver health, keeping the Korean biotech in the hunt for a market already served by Novo Nordis...

Experts warn of dosing issues with GLP-1 weight loss drugs

While many patients are seeing life-changing results with GLP-1 medications, doctors say the medications can also come with risks if they are not dosed properly.

GLP-1 Receptor Agonist Weight Loss Therapy and Arthroplasty: Are Women at Greater Risk for Complications?

The GLP-1 receptor agonists have profoundly revolutionized metabolic therapy. These agents have rapidly become central to obesity management, producing substantial effects on weigh...

Brain-cell breakthrough supercharges GLP-1 weight loss and prevents plateaus

Scientists have identified a new way to supercharge the GLP-1 receptor agonist semaglutide, opening the door to boosting the drug's weight-loss power and helping long-term users pu...

GLP-1 Experimentation Is Everywhere, and Science Can’t Keep Up

Millions of Americans are experimenting with the drugs. Science can’t keep up.

GLP-1 Weight Loss Linked To Dramatically Lower Risk of Sleep Apnea, Kidney Disease and More

New research indicates that maintaining meaningful weight loss after starting GLP-1-based therapies could play an important role in reducing the risk of multiple obesity-related di...

Doctors Reveal The Most Common Side Effects Of GLP-1s — And How To Manage Them

Ozempic, Wegovy and other GLP-1 medications are popular but can cause unwanted health concerns.

Popular Weight-Loss Drugs Found To Cut Heart Attack and Stroke Risk

A large-scale analysis suggests that GLP-1 receptor agonists may do more than manage weight or blood sugar. New research suggests that GLP-1 weight loss drugs may provide lasting p...